<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02277665</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00028307 D14233</org_study_id>
    <secondary_id>5R01DA032243</secondary_id>
    <nct_id>NCT02277665</nct_id>
  </id_info>
  <brief_title>Clinical Trial Tobacco Marijuana</brief_title>
  <acronym>RCTTM</acronym>
  <official_title>Randomized Trial Evaluating Treatment for Cannabis Use Disorders Among Those Who Use Tobacco</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 50% of persons seeking treatment for cannabis-use disorders (CUDs) regularly
      smoke tobacco. Combining tobacco with cannabis has become a common method of smoking
      cannabis. Similarities of use, and using together, can make quitting difficult. Stopping
      tobacco simultaneously with cannabis may be beneficial. Little scientific information
      currently addresses how to best target tobacco smoking during treatment for CUDs. Our
      long-term goal is to develop an effective protocol for intervening in tobacco smoking without
      changing cannabis outcomes.

      This protocol reflects the planned Stage 1, proof-of-concept study that will compare a
      combined cannabis and tobacco intervention to one that targets CUD only. Hypotheses assert
      that the intervention (1) will be accepted by the majority of eligible participants (2) will
      result in more tobacco quit attempts and rates than the CUD-only treatment; and (3) will not
      adversely affect cannabis outcomes. Last, the project will evaluate the potential of specific
      moderators of outcomes to predict outcomes and inform subsequent treatment development
      efforts. If the hypotheses were confirmed, dissemination of this protocol would reduce
      adverse psychosocial and health consequences of tobacco or cannabis dependence. Findings will
      inform future development of prevention and intervention strategies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 18, 2014</start_date>
  <completion_date type="Actual">January 18, 2017</completion_date>
  <primary_completion_date type="Actual">January 18, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tobacco Quit Attempts</measure>
    <time_frame>Week 12</time_frame>
    <description>Percent of Participants who made at least one tobacco quit attempt</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tobacco Abstinence</measure>
    <time_frame>Weeks 9-12</time_frame>
    <description>the percent of participants who achieve sustained tobacco abstinence, which reflects biologically-verified abstinence during weeks 5-12</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cannabis Abstinence</measure>
    <time_frame>Weeks 1-12</time_frame>
    <description>number of participants who achieved at least one week of documented cannabis abstinence during treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weeks of Continuous Cannabis Abstinence</measure>
    <time_frame>Weeks 1-12</time_frame>
    <description>Weeks of Continuous Cannabis Abstinence among those achieving at least one week of abstinence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Attendance</measure>
    <time_frame>12 weeks</time_frame>
    <description>Attendance operationalized as the number of clinic visits (urine specimens provided)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Initiation of Nicotine Replacement Therapy (NRT)</measure>
    <time_frame>24 weeks</time_frame>
    <description># of participants who initiated NRT during the 24 week study period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Cannabis Use Disorder</condition>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>CUD Treatment Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CUD and Tobacco Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CUD Treatment</intervention_name>
    <arm_group_label>CUD Treatment Only</arm_group_label>
    <arm_group_label>CUD and Tobacco Treatment</arm_group_label>
    <other_name>Cognitive Behavioral Therapy and Contingency Management</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tobacco Treatment</intervention_name>
    <arm_group_label>CUD and Tobacco Treatment</arm_group_label>
    <other_name>Behavioral Counseling plus NRT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Individuals must be 18 years or older

          2. Individuals must meet criteria for the current Diagnostic and Statistical Manual -IV
             diagnosis of cannabis abuse or dependence, report use of cannabis on at least 45 of
             the previous 90 days, and report regular use of tobacco cigarettes or report that
             their primary administration of cannabis is via blunts or spliffs

          3. Individual must indicate that they have at least some interest in quitting tobacco in
             the next 6 months (rating of 2 or more on a 5-point interest scale)

        Exclusion Criteria:

          1. Current dependence on alcohol or any drug other than tobacco and cannabis

          2. Use of non-tobacco nicotine

          3. Current participation in structured treatment for substance abuse

          4. Severe psychological distress (e.g., active suicidal plans, psychosis, debilitating
             panic disorder)

          5. Report of a condition that requires seeing a physician before using NRT (e.g.,
             pregnancy or recent heart attack); note: if a participant's physician approves taking
             NRT, we will consider enrolling them

          6. Legal status that would interfere with participation

          7. Living with someone currently enrolled in the project

          8. Not being fluent in English

          9. Not living within 45 miles of the research site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan J Budney, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Denise Walker, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington School of Social Work</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geisel School of Medicine at Dartmouth; State Building Site</name>
      <address>
        <city>Concord</city>
        <state>New Hampshire</state>
        <zip>03301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisel School of Medicine at Dartmouth; Rivermill Complex Site</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington School of Social Work</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>October 27, 2014</study_first_submitted>
  <study_first_submitted_qc>October 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2014</study_first_posted>
  <results_first_submitted>November 21, 2018</results_first_submitted>
  <results_first_submitted_qc>December 17, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">January 8, 2019</results_first_posted>
  <last_update_submitted>December 17, 2018</last_update_submitted>
  <last_update_submitted_qc>December 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Alan J. Budney</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cannabis Use Disorder</keyword>
  <keyword>Tobacco Use</keyword>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Marijuana Abuse</mesh_term>
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/65/NCT02277665/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled between 12/2014 to 09/2016 at Dartmouth College and the University of Washington. Participants were recruited from ads posted online (Craigslist, Facebook), in newspapers, on radio, community posters, and notices to service agencies. All activities occurred at stand-alone, University associated research clinics.</recruitment_details>
      <pre_assignment_details>All those who enrolled were assigned to a treatment condition</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CUD Treatment Only</title>
          <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
CUD Treatment</description>
        </group>
        <group group_id="P2">
          <title>CUD and Tobacco Treatment</title>
          <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco
CUD Treatment
Tobacco Treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CUD Treatment Only</title>
          <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
CUD Treatment</description>
        </group>
        <group group_id="B2">
          <title>CUD and Tobacco Treatment</title>
          <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco
CUD Treatment
Tobacco Treatment</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="67"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.3" spread="12.2"/>
                    <measurement group_id="B2" value="31.7" spread="11.2"/>
                    <measurement group_id="B3" value="34.0" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Tobacco Quit Attempts</title>
        <description>Percent of Participants who made at least one tobacco quit attempt</description>
        <time_frame>Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CUD Treatment Only</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
CUD Treatment</description>
          </group>
          <group group_id="O2">
            <title>CUD and Tobacco Treatment</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco
CUD Treatment
Tobacco Treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Tobacco Quit Attempts</title>
          <description>Percent of Participants who made at least one tobacco quit attempt</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Chi-square</non_inferiority_desc>
            <p_value>= 0.33</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.56</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.17</ci_lower_limit>
            <ci_upper_limit>1.82</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tobacco Abstinence</title>
        <description>the percent of participants who achieve sustained tobacco abstinence, which reflects biologically-verified abstinence during weeks 5-12</description>
        <time_frame>Weeks 9-12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CUD Treatment Only</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
CUD Treatment</description>
          </group>
          <group group_id="O2">
            <title>CUD and Tobacco Treatment</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco
CUD Treatment
Tobacco Treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Tobacco Abstinence</title>
          <description>the percent of participants who achieve sustained tobacco abstinence, which reflects biologically-verified abstinence during weeks 5-12</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.57</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.32</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cannabis Abstinence</title>
        <description>number of participants who achieved at least one week of documented cannabis abstinence during treatment</description>
        <time_frame>Weeks 1-12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CUD Treatment Only</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
CUD Treatment</description>
          </group>
          <group group_id="O2">
            <title>CUD and Tobacco Treatment</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco
CUD Treatment
Tobacco Treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Cannabis Abstinence</title>
          <description>number of participants who achieved at least one week of documented cannabis abstinence during treatment</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>= 0.16</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.45</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.15</ci_lower_limit>
            <ci_upper_limit>1.35</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Weeks of Continuous Cannabis Abstinence</title>
        <description>Weeks of Continuous Cannabis Abstinence among those achieving at least one week of abstinence</description>
        <time_frame>Weeks 1-12</time_frame>
        <population>All participants</population>
        <group_list>
          <group group_id="O1">
            <title>CUD Treatment Only</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
CUD Treatment</description>
          </group>
          <group group_id="O2">
            <title>CUD and Tobacco Treatment</title>
            <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco
CUD Treatment
Tobacco Treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Weeks of Continuous Cannabis Abstinence</title>
          <description>Weeks of Continuous Cannabis Abstinence among those achieving at least one week of abstinence</description>
          <population>All participants</population>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="3.7"/>
                    <measurement group_id="O2" value="5.9" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.87</p_value>
            <method>Chi-squared</method>
            <param_type>Means Ratio</param_type>
            <param_value>0.97</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>1.42</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Treatment Attendance</title>
        <description>Attendance operationalized as the number of clinic visits (urine specimens provided)</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CUD Treatment</title>
            <description>Received CUD treatment and delayed Tobacco Intervention</description>
          </group>
          <group group_id="O2">
            <title>CUD Treatment and Tobacco Intervention</title>
            <description>Received CUD treatment and Tobacco Intervention simultaneously</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Attendance</title>
          <description>Attendance operationalized as the number of clinic visits (urine specimens provided)</description>
          <units>visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" spread="9.0"/>
                    <measurement group_id="O2" value="9.7" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.46</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Initiation of Nicotine Replacement Therapy (NRT)</title>
        <description># of participants who initiated NRT during the 24 week study period</description>
        <time_frame>24 weeks</time_frame>
        <population>All participants included in analysis</population>
        <group_list>
          <group group_id="O1">
            <title>CUD Treatment</title>
            <description>Received CUD treatment and delayed Tobacco Intervention</description>
          </group>
          <group group_id="O2">
            <title>CUD Treatment and Tobacco Intervention</title>
            <description>Received CUD treatment and Tobacco Intervention simultaneously</description>
          </group>
        </group_list>
        <measure>
          <title>Initiation of Nicotine Replacement Therapy (NRT)</title>
          <description># of participants who initiated NRT during the 24 week study period</description>
          <population>All participants included in analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Two years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>CUD Treatment Only</title>
          <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
CUD Treatment</description>
        </group>
        <group group_id="E2">
          <title>CUD and Tobacco Treatment</title>
          <description>12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco
CUD Treatment
Tobacco Treatment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>pruritus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Enrollment did not meet planned target numbers, limiting the power to detect differences between conditions.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Alan J. Budney</name_or_title>
      <organization>Dartmouth-Hitchcock</organization>
      <phone>603-646-7088</phone>
      <email>alan.j.budney@dartmouth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

